AZTR - Azitra, Inc.

0.1804
0.004   2.439%

Share volume: 322,256
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
42%
Profitability 35%
Dept financing 31%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
9.73%
1 Month
-10.20%
3 Months
-53.02%
6 Months
-77.37%
1 Year
-48.46%
2 Year
-20.84%
Key data
Stock price
$0.18
P/E Ratio 
N/A
DAY RANGE
$0.18 - $0.18
EPS 
-$1.99
52 WEEK RANGE
$0.13 - $1.40
52 WEEK CHANGE
-$48.31
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
16.192 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
2.31
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,073,199
AVERAGE 30 VOLUME 
$1,735,144
Company detail
CEO: Francisco D. Salva
Region: US
Website: azitrainc.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. We were incorporated under the laws of the state of Delaware on January 2, 2014. Our principal executive offices are located at 21 Business Park Drive, Branford, Connecticut.

Recent news